LONG-TERM SURVIVAL OF A PATIENT WITH ERYTHROLEUKEMIA FOLLOWING INTERFERON ALPHA-2B TREATMENT

被引:0
|
作者
STEGER, GG
DITTRICH, C
PRISCHL, FC
SCHWARZMEIER, JD
机构
[1] VIENNA UNIV,DEPT CHEMOTHERAPY,A-1010 VIENNA,AUSTRIA
[2] VIENNA UNIV,DEPT MED 1,A-1010 VIENNA,AUSTRIA
来源
BLUT | 1988年 / 57卷 / 04期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:209 / 209
页数:1
相关论文
共 50 条
  • [1] LONG-TERM REMISSION IN A PATIENT WITH ERYTHROLEUKEMIA FOLLOWING INTERFERON-ALPHA TREATMENT
    STEGER, GG
    DITTRICH, C
    CHOTT, A
    DERFLER, K
    SCHWARZMEIER, JD
    [J]. JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (04): : 351 - 354
  • [2] INTERFERON ALPHA-2B IN THE LONG-TERM TREATMENT OF ESSENTIAL THROMBOCYTHEMIA
    SACCHI, S
    TABILIO, A
    LEONI, P
    RICCARDI, A
    VECCHI, A
    MESSORA, C
    FALZETTI, F
    RUPOLI, S
    UCCI, G
    MARTELLI, MF
    [J]. ANNALS OF HEMATOLOGY, 1991, 63 (04) : 206 - 209
  • [3] Trichomegaly following treatment with interferon alpha-2b
    Hernández-Núnéz, A
    Fernández-Herrera, J
    Buceta, LR
    García-Díez, A
    [J]. LANCET, 2002, 359 (9312): : 1107 - 1107
  • [4] Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individuals
    Rivero, J
    Fraga, M
    Cancio, I
    Cuervo, J
    LopezSaura, P
    [J]. BIOTHERAPY, 1997, 10 (02) : 107 - 113
  • [5] NEUROTOXIC EFFECTS OF LONG-TERM TREATMENT WITH LOW-DOSE ALPHA-2B INTERFERON
    IAFFAIOLI, RV
    FIORENZA, L
    DAVINO, M
    FRASCI, G
    LAMURA, G
    GROSSI, D
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1990, 48 (03): : 403 - 408
  • [6] LONG-TERM ALPHA-2B INTERFERON (ALPHA-2BIFN) THERAPY IN CHRONIC HCV INFECTION
    VANDELLI, C
    RENZO, F
    PALMISANI, L
    VECCHI, C
    FLORIDIA, A
    SPAGNOLO, V
    VENTURA, E
    [J]. HEPATOLOGY, 1993, 18 (04) : A260 - A260
  • [7] INTERFERON ALPHA-2B IN THE TREATMENT OF MYELOFIBROSIS
    FURESI, L
    PASINI, FL
    FORCONI, S
    [J]. HAEMATOLOGICA, 1990, 75 (06) : 587 - 589
  • [8] Long-term results regarding the use of recombinant interferon alpha-2b in the treatment of II type mixed essential cryoglobulinemia
    Lauta, VM
    DeSangro, MA
    [J]. MEDICAL ONCOLOGY, 1995, 12 (04): : 223 - 230
  • [9] TREATMENT WITH NATURAL HUMAN INTERFERON ALPHA OF A CML-PATIENT WITH ANTIBODIES TO RECOMBINANT INTERFERON ALPHA-2B
    FREUND, M
    VONWUSSOW, P
    KNUVERHOPF, J
    MOHR, H
    POHL, U
    EXERIEDE, G
    LINK, H
    WILKE, HJ
    POLIWODA, H
    [J]. BLUT, 1988, 57 (05): : 311 - 315
  • [10] TREATMENT OF ESSENTIAL THROMBOCYTHEMIA WITH INTERFERON ALPHA-2B
    MAY, D
    WANDL, UB
    NIEDERLE, N
    [J]. LANCET, 1989, 1 (8629): : 96 - 96